Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther. 2000 Dec; 2(6):545-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.